Fiber supplements and clinically meaningful health benefits: Identifying the physiochemical characteristics of fiber that drive specific physiologic effects

Dietary Supplements in Health Promotion

Volumn , Issue , 2015, Pages 161-205

  McRorie, Johnson W ^a   Fahey, George C ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85132963124     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (165)

1. Institute of Medicine, Food and Nutrition Board. 2002. Dietary reference intakes: Energy, carbohydrates, fiber, fat, fatty acids cholesterol, protein and amino acids. Washington, DC: National Academies Press.
2. Panel on Macronutrients, Panel on the Definition of Dietary Fiber, Subcommittee on Upper Reference Levels of Nutrients, Subcommittee on Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. 2002/2005. Dietary reference intakes for energy, carbohydrate, fiber, fatty acids, cholesterol, protein, and amino acids. Washington, DC, USA: The National Academies Press.
3. Slavin JL. 2008. Position of the American Dietetic Association: Health implications of dietary fiber. J Am Diet Assoc. 108, 1716-1731.
4. Chutkan R, Fahey G, Wright W, McRorie J. 2012. Viscous versus non-viscous soluble fiber supplements: Mechanisms and evidence for fiber-specific health benefits. J Am Acad Nurse Pract. 24, 476-487.
5. McRorie J, Fahey G. 2013. A review of gastrointestinal physiology and the mechanisms underlying the health benefits of dietary fiber: Matching an effective fiber with specific patient needs. Clin Nurs Stud. 1(4), 82-92.
6. Klosterbuer A, Roughead Z, Slavin J. 2011. Benefits of dietary fiber in clinical nutrition. JNutr Clin Pract. 26(5), 625-635.
7. Reicks M, Jonnalagadda S, Albertson AM, Joshi N. 2014. Total dietary fiber intakes in the US population are related to whole grain consumption: Results from the National Health and Nutrition Examination Survey 2009 to 2010. Nutr Res. 34(3), 226-234.
8. Slavin J, Green H. 2007. Dietary fiber and satiety. Nutr Bull. 32, 32-42.
9. Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. 2002/2005 and Dietary Reference Intakes for water, potassium, sodium, chloride, and sulfate 2005. http://www.nal.usda.gov/fnic/DRI/DRI_Energy/energy_full_report.pdf
10. U.S. Department of Health and Human Services; U.S. Department of Agriculture. 2010. Dietary Guidelines for Americans. Washington, DC, USA: Government Printing Office.
11. Slavin JL. 2005. Dietary fiber and body weight. Nutrition 21, 411-418.
12. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. 1996. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. J Am Med Assoc. 275, 447-451.
13. Mozaffarian D, Kumanyika SK, Lemaitre RN, Olson JL, Burke GL, Siscovick DS. 2003. Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. J Am Med Assoc. 289, 1659-1666.
14. Wolever TM. 2013. Is glycaemic index (GI) a valid measure of carbohydrate quality? Eur J Clin Nutr. 67(5), 522-531.
15. A Report of the Panel on Macronutrients Subcommittees on Upper Reference Levels of Nutrients Interpretation Uses of Dietary Reference Intakes Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. 2005. In: Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). Washington, DC, USA: The National Academies Press. http://www.nap.edu/catalog/10490/dietary-reference-intakes-for-energy-carbohydrate-fiber-fat-fatty-acids-cholesterol-protein-and-amino-acids-macronutrients.
16. Dikeman C, Fahey G. 2006. Viscosity as related to dietary fiber: A review. Crit Rev Food Sci Nutr. 46, 649-663.
17. Guillon F, Champ MM. 2002. Carbohydrate fractions of legumes: Uses in human nutrition and potential for health. Br J Nutr. 88 (Suppl 3), S293-S306.
18. Morris ER, Cutler AN, Ross-Murphy DA, Rees DA, Price J. 1981. Concentration and shear rate dependence of viscosity in random coil polysaccharide solutions. Carbohydr Polym. 1, 5-21.
19. Anderson JW. 2009. All fibers are not created equal. J Med. 2, 87-91.
20. Kim J, Cha YJ, Lee KH, Park E. 2013. Effect of onion peel extract supplementation on the lipid profile and antioxidative status of healthy young women: A randomized, placebo-controlled, double-blind, crossover trial. Nutr Res Pract. 7(5), 373-379.
21. Code of Federal Regulations, Title 21: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=101.81.
22. Wolever T, Tosh S, Gibbs A et al. 2010. Physicochemical properties of oat ß-glucan influence its ability to reduce serum LDL cholesterol in humans: A randomized clinical trial. Am J Clin Nutr. 92, 723-732.
23. Vuksan V, Jenkins AL, Rogovik AL, Fairgrieve CD, Jovanovski E, Leiter LA. 2011. Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals. Br J Nutr. 106, 1349-1352.
24. Schwartz SE, Levine RA, Singh A, Scheidecker JR, Track NS. 1982. Sustained pectin ingestion delays gastric emptying. Gastroenterology. 83(4), 812-817.
25. Whitman WB, Coleman DC, Wiebe WJ. 1998. Prokaryotes: The unseen majority. Proc Natl Acad Sci USA. 95, 6578-6583.
26. Ley RE, Peterson DA, Gordon JI. 2006. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 124, 837-848.
27. Cummings JH, Macfarlane GT, Englyst HN. 2001. Prebiotic digestion and fermentation. Am J Clin Nutr. 73(Suppl 2), 415S-420S.
28. Suarez FL, Levitt MD. 2000. An understanding of excessive intestinal gas. Current Gastroenterology Reports. 2, 413-419.
29. Suarez FL, Furne JK, Springfield JR, Levitt MD. 1998. Identification of gases responsible for the odor of human flatus and evaluation of a device purported to reduce this odor. Gut. 43, 100-104.
30. Levitt MD. 1971. Volume and composition of human intestinal gas determined by means of an intestinal washout technique. N Engl J Med. 284, 1394-1398.
31. McRorie J, Greenwood-Van Meerveld B, Rudolph C. 1998. Characterization of propagating contractions in the proximal colon of ambulatory mini pigs. Dig Dis Sci. 43(5), 957-963.
32. Levitt M. 1979. Follow-up of a flatulent patient. Dig Dis Sci. 24(8), 652-654.
33. Campbell J, Fahey G. 1997. Psyllium and methylcellulose fermentation properties in relation to insoluble and soluble fiber standards. Nutr Res. 17, 619-629.
34. Kaur A, Rose D, Rumpagaporn P et al. 2011. In vitro batch fecal fermentation comparison of gas and short-chain fatty acid production using "slowly fermentable" dietary fibers. J Food Sci. 76, H137-H142.
35. Timm D, Stewart M, Hospattankar A et al. 2010. Wheat dextrin, psyllium, and inulin produce distinct fermentation patterns, gas volumes, and short-chain fatty acid profiles in vitro. J Med Food. 13, 961-966.
36. Wolever T, ter Wal P, Spadafora P et al. 1992. Guar, but not psyllium, increases breath methane and serum acetate concentrations in human subjects. Am J Clin Nutr. 55, 719-722.
37. Levitt MD, Furne J, Olsson S. 1996. The relation of passage of gas and abdominal bloating to colonic gas production. Ann Intern Med. 124, 422-424.
38. Zumarraga L, Levitt M, Suarez F. 1997. Absence of gaseous symptoms during ingestion of commercial fibre preparations. Aliment Pharmacol Ther. 11, 1067-1072.
39. Wolever T, Robb P 1992. Effect of guar, pectin, psyllium, soy polysaccharide and cellulose on breath hydrogen and methane in healthy subjects. Am J Gastroenterol. 87, 305-310.
40. Marteau P, Flourié B, Cherbut C et al. 1994. Digestibility and bulking effect of ispaghula husks in healthy humans. Gut. 35, 1747-52.
41. Roberfroid M. 2007. Prebiotics: The concept revisited. J Nutr. 137, 830S-837S.
42. Scientific opinion on the substantiation of health claims related to various food(s)/food constituents(s) and increasing numbers of gastro-intestinal microorganisms (ID 760, 761, 779, 780, 779, 1905), and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 760, 761, 779, 780, 779, 1905) pursuant to Article 13(1) of Regulation (EC) No 1924/2006).
43. Department of Agriculture. Carbohydrates (Dietary Guidelines for Americans), 2010. Available at: http://www.cnpp.usda.gov/Publications/DietaryGuidelines/2010/DGAC/Report/D-5-Carbohydrates.pdf (accessed on October 6, 2011).
44. Meyer J, Ohashi H, Jehn D, Thompson J. 1981. Size of liver particles emptied from the human stomach. Gastroenterology. 80, 1489-1496.
45. Holt S, Heading RC, Carter DC, Prescott LF, Tothill P 1979. Effect of gel fibre on gastric emptying and absorption of glucose and paracetamol. Lancet. 24;1(8117), 636-639.
46. Todd PA, Benfield P, Goa KL. 1990. Guar gum a review of its pharmacological properties, and use as a dietary adjunct in hypercholesterolaemia. Drugs. 39, 917-928.
47. Bianchi M, Capurso L. 2002. Effects of guar gum, psyllium and microcrystalline cellulose on abdominal symptoms, gastric emptying, orocaecal transit time and gas production in healthy volunteers. Dig Liver Dis. 34 (Suppl 2), S129-S133.
48. van Nieuwenhoven M, Kovacs E, Brummer R, Westerterp-Plantenga M, Brouns F. 2001. The effect of different dosages of guar gum on gastric emptying and small intestinal transit of a consumed semisolid meal. Am Coll Nutr. 20(1), 87-91.
49. Schwartz SE, Levine RA, Singh A, Scheidecker JR, Track NS. 1982. Sustained pectin ingestion delays gastric emptying. Gastroenterology. 83(4), 812-817.
50. Kawasaki N, Suzuki Y, Urashima M, Nakayoshi T, Tsuboi K, Tanishima Y, Hanyu N, Kashiwagi H. 2008. Effect of gelatinization on gastric emptying and absorption. Hepatogastroenterology. 55(86-87), 1843-1845.
51. Sandhu KS, el Samahi MM, Mena I, Dooley CP, Valenzuela JE. 1987. Effect of pectin on gastric emptying and gastroduodenal motility in normal subjects. Gastroenterology. 92(2), 486-492.
52. Rigaud D, Paycha F, Meulemans A, Merrouche M, Mignon M. 1998. Effect of psyllium on gastric emptying, hunger feeling and food intake in normal volunteers: A double blind study. Eur J Clin Nutr. 52(4), 239-245.
53. Guyton A, Hall J. 2006. Textbook of Medical Physiology, 11th edition. Philadelphia, PA: Elsevier Inc., Unit XII, Chapters 62-66.
54. Lobo D, Hendry P, Rodrigues G, Marciani L, Totman J, Wright J, Preston T, Gowland P, Spiller R, Fearon K. 2009. Gastric emptying of three liquid oral preoperative metabolic preconditioning regimens measured by magnetic resonance imaging in healthy adult volunteers: A randomized double-blind, crossover study. Clin Nutr. 28, 636-641.
55. Bergmann JF, Chassany O, Petit A, Triki R, Caulin C, Segrestaa JM. 1992. Correlation between echographic gastric emptying and appetite: Influence of psyllium. Gut. 33, 1042-1043.
56. Jenkins DJ, Wolever TM, Taylor RH et al. 1981. Glycemic index of foods: A physiological basis for carbohydrate exchange. Am J Clin Nutr. 34, 362-366.
57. Morris, ER, Cutler, AN, Ross-Murphy, DA, Rees, DA, and Price, J. 1981. Concentration and shear rate dependence of viscosity in random coil polysaccharide solutions. Carbohydr Polym. 1, 5-21.
58. Schirra J, Goke B. 2005. The physiological role of GLP-1 in human: Incretin, ileal brake or more? Regul Pept. 128, 109-115.
59. Dikeman C, Murphy M, Fahey G. 2006. Dietary fibers affect viscosity of solutions and simulated human gastric and small intestine digesta. J Nutr. 136, 913-919.
60. Jenkins D, Wolever T, Taylor R, Barker H, Fielden H, Baldwin J, Bowling A, Newman H, Jenkins A, Goff D. 1981. Glycemic index of foods: A physiological basis for carbohydrate exchange. Am J Clin Nutr. 34, 362-366.
61. Wolever T, Jenkins D. 1986. The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr. 43, 167-172.
62. Maljaars P, Peters H, Mela D, Masclee A. 2008. Ileal brake: A sensible food target for appetite control. A review. Physiol Behav. 95, 271-281.
63. Holst J, Deacon C, Vilsbpll T, Krarup T, Madsbad S. 2008. Glucagon-like peptide-1, glucose homeostasis and diabetes. Trends Mol Med. 14, 161-168.
64. Maljaars P, Peters H, Kodde A, Geraedts M, Troost F, Haddeman E, Masclee A. 2011. Length and site of the small intestine exposed to fat influences hunger and food intake. Br J Nutr. 106, 1609-1615.
65. Anderson JW, Floore TL, Geil PB, O'Neal DS, Balm TK. 1991. Hypocholesterolemic effects of different bulk-forming hydrophilic fibers as adjuncts to dietary therapy in mild to moderate hypercholesterolemia. Arch Intern Med. 151(8), 1597-1602.
66. McRorie J, Pepple S, Rudolph C. 1998. Effects of fiber laxatives and calcium docusate on regional water content and viscosity of digesta in the large intestine of the pig. Dig Dis Sci. 43(4), 738-745.
67. Jenkins D, Wolever T, Leeds A et al. 1978. Dietary fibres, fibre analogues, and glucose tolerance: Importance of viscosity. Br Med J. 1, 1392-1394.
68. Jarjis H, Blackburn N, Redfern J, Read N. 1984. The effect of ispaghula (Fybogel and Metamucil) and guar gum on glucose tolerance in man. Br J Nutr. 51, 371-378.
69. Wolever T, Vuksan V, Eshuis H, Spadafora P, Peterson R, Chao E, Storey M, Jenkins D. 1991. Effect of method of administration of psyllium on glycemic response and carbohydrate digestibility. J Am Coll Nutr. 10, 364-371.
70. Cherbut C et al. 1994. Digestibility and bulking effect of ispaghula husks in healthy humans. Gut. 35, 1747-1752.
71. Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP. 2002. Therapeutic effects of psylliumin type 2 diabetic patients. Eur J Clin Nutr. 56(9), 830-842.
72. Anderson J, Zettwoch N, Feldman T, Tietyen-Clark J, Oeltgen P, Bishop C. 1988. Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholetserol-emic men. Arch Intern Med. 148, 292-296.
73. Bell LP, Hectorne K, Reynolds H, Balm TK, Hunninghake DB. 1989. Cholesterollowering effects of psyllium hydrophilic mucilloid. Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. JAMA. 261(23), 3419-3423.
74. Levin EG, Miller VT, Muesing RA, Stoy DB, Balm TK, LaRosa JC. 1990. Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Arch Intern Med. 150(9), 1822-1827.
75. Cicero AFG, Derosa G, Bove M et al. 2010. Psyllium improves dyslipidemaemia, hyperglycaemia and hypertension, while guar gum reduces body weight more rapidly in patients affected by metabolic syndrome following an AHA Step 2 diet. Mediterr J Nutr Metab. 3, 47-54.
76. Rodriguez-Moran M, Guerrero-Romero F, Laczano-Burciaga L et al. 1998. Lipid-and glucose-lowering efficacy of plantagopsyllium in type II diabetes. J Diab Complicat. 12, 273-278.
77. Ziai S, Larijani B, Akhoondzadeh S et al. 2005. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol. 102, 202-207.
78. Dall'Alba V, Silva FM, Antonio JP, Steemburgo T, Royer CP, Almeida JC, Gross JL, Azevedo MJ. 2013. Improvement of the metabolic syndrome profile by soluble fibreguar gum-in patients with type 2 diabetes: A randomised clinical trial. Br JNutr. 110(9), 1601-1610.
79. Gupta RR, Agrawal CG, Singh GP et al. 1994. Lipid-lowering efficacy of psyllium hydrophilic mucilloid in non-insulin dependent diabetes mellitus with hyperlipidemia. Ind J Med Res. 100, 237-241.
80. Anderson J, Allgood L, Turner C, Oelgten P, Daggy B. 1999. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr. 70, 466-473.
81. Feinglos M, Gibb R, Ramsey D, Surwit R, McRorie J. 2013. Psyllium improves glycemic control in patients with type-2 diabetes mellitus. Bioact Carbohydr Diet Fibre. 1, 156-161.
82. Tosh SM. 2013. Review of human studies investigating the post-prandial blood-glucose lowering ability of oat and barley food products. Eur J Clin Nutr. 67(4), 310-317.
83. Sartore G, Carlström S, Scherstén B. 1981. Dietary supplementation of fibre (Lunelax) as a means to reduce postprandial glucose in diabetics. Acta Med Scand Suppl. 656, 51-53.
84. Karmally W, Montez M, Palmas W, Martinez W, Branstetter A, Ramakrishnan R, Holleran S, Haffner S, Ginsberg H. 2005. Cholesterol-lowering benefits of oat-containing cereal in Hispanic Americans. J Am Diet Assoc. 105, 967-970.
85. Keogh G, Cooper G, Mulvey T, Mcardle B, Coles G, Monro J, Poppitt S. 2003. Randomized controlled cross-over study of the effect of a highly ß-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr 78, 711-718.
86. Kerkhoffs D, Hornstra G, Mensick R. 2003. Cholesterol-lowering effect of ß-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when ß-glucan is incorporated into bread and cookies. Am J Clin Nutr. 78, 221-227.
87. Naumann E, Van Rees A, Onning G, Oste R, Wydra M, Mensick R. 2006. ß-glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations. Am J Clin Nutr. 83, 601-605.
88. Beer M, Arrigoni E, Amado R. 1995. Effects of oat gum on blood cholesterol levels in healthy young men. Eur J Clin Nutr. 49, 517-522.
89. Delahoy PJ, Magliano DJ, Webb K, Grobler M, Liew D. 2009. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: An updated meta-analysis. Clin Ther. 31, 236-244.
90. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R; Stresa Workshop Participants. 2003. Efficacy and safety of plants tanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc. 78(8), 965-978.
91. Gunness P, Gidley M. 2010. Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides. Food Funct. 1, 149-155.
92. Jensen C, Spiller G, Gates J, Miller A, Whittam J. 1993. The effect of acacia gum and a water-soluble dietary fiber mixture on blood lipids in humans. J Am Coll Nutr. 12(2), 147-154.
93. Haskell WL, Spiller GA, Jensen CD, Ellis BK, Gates JE. 1992. Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects. Am J Cardiol. 69(5), 433-439.
94. Brownawell AM, Caers W, Gibson GR, Kendall CW, Lewis KD, Ringel Y, Slavin JL. 2012. Prebiotics and the health benefits of fiber: Current regulatory status, future research, and goals. J Nutr. 142(5), 962-974.
95. Shrestha S, Volek JS, Udani J, Wood RJ, Greene CM, Aggarwal D, Contois JH, Kavoussi B, Fernandez ML. 2006. A combination therapy including psyllium and plant sterols lowers LDL cholesterol by modifying lipoprotein metabolism in hypercholesterolemic individuals. J Nutr. 136(10), 2492-2497.
96. Shrestha S, Freake H, McGrane M, Volek J, Fernandez M. 2007. A combination of psyllium and plant sterols alter lipoprotein metabolism in hypercholesterolemic subjects by modifying the intravascular processing of lipo proteins and increasing LDL uptake. J Nutr 137(5), 1165-1170.
97. Neal G, Balm T. 1990. Synergistic effects of psyllium in the dietary treatment of hyper-cholesterolemia. South Med J. 83, 1131-1137.
98. Moreyra AE, Wilson AC, Koraym, A. 2005. Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Arch Int Med. 165, 1161-1166.
99. Maciejko JJ, Brazg R, Shah A, Patil S, Rubenfire M. 1994. Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hyper-cholesterolemia. Arch Fam Med. 3, 955-960.
100. Spence J, Huff M, Heidenheim P et al. 1995. Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia. Ann Int Med. 123, 493-499.
101. Agrawal A, Tandon M, Sharma, P. 2007. Effect of combining viscous fibre with lavastatin on serum lipids in normal human subjects. Int J Clin Pract. 61, 1812-1818.
102. Jayaram S, Prasad HB, Sovani VB, Langade DG, Mane PR. 2007. Randomised study to compare the efficacy and safety of is apgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia. J Indian Med Assoc. 105(3), 142-145.
103. Roberts D, Truswell A, Bencke A, Dewar H, Farmakalidis E. 1994. The cholesterollowering effect of a breakfast cereal containing psyllium fibre. Med J Aust. 161, 660-664.
104. CDC. Overweight and Obesity. Available at http://www.cdc.gov/obesity/data/adult.html (accessed on March 11, 2015).
105. Anderson J, Baird P, Davis R et al. 2009. Health benefits of dietary fiber. Nutr Rev. 67, 188-205.
106. Du H, van der ADL, Boshuizen HC et al. 2010. Dietary fiber and subsequent changes in body weight and waist circumference in European men and women. Am J Clin Nutr. 91, 329-336.
107. Liu S, Willett WC, Manson JE, Hu FB, Rosner B, Colditz G. 2003. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr. 78, 920-927.
108. Duncan LJP, Rose K, Meikeljohn AP. 1960. Phenmetrazine hydrochloride and methylcellulose in the treatment of "refractory" obesity. Lancet 1, 1262-1265.
109. Yudkin J. 1959. The causes and cure of obesity. Lancet 2, 1135-1138.
110. Davis J, Hodges V, Gillham M. 2006. Normal-weight adults consume more fiber and fruit than their age-and height-matched overweight/obese counterparts. J Am Diet Assoc. 106, 833-840.
111. Tucker L, Thomas K. 2009. Increasing total fiber intake reduces risk of weight and fat gains in women. J Nutr. 139, 576-581.
112. Blackwood AD, Salter J, Dettmar PW, Chaplin MF. 2000. Dietary fibre, physicochemical properties and their relationship to health. J R Soc Promot Health. 120, 242-247.
113. Howarth N, Saltzman E, Roberts S. 2001. Dietary fiber and weight regulation. Nutr Rev. 59, 129-139.
114. Pereira M, Ludwig D. 2001. Dietary fiber and body-weight regulation: Observations and mechanisms. Pediatr Clin North Am. 48, 969-980.
115. Slavin J. 2005. Dietary fiber and body weight. Nutrition. 21, 411-418.
116. Higgins J. 2014. Resistant starch and energy balance: Impact on weight loss and maintenance. Crit Rev Food Sci Nutr. 54, 1158-1166.
117. Abrams S, Griffin I, Hawthorne K, Ellis KJ. 2007. Effect of prebiotic supplementation and calcium intake on body mass index. Pediatr. 151(3), 293-298.
118. Wanders A, van den Borne J, de Graaf C, Hulshof T, Jonathan M, Kristensen M et al. 2011. Effects of dietary fibre on subjective appetite, energy intake and body weight: A systematic review of randomized controlled trials. Obes Rev. 12, 724-739.
119. Archer B, Johnson S, Devereux H, Baxter A. 2004. Effect of fat replacement by inulin or lupin-kernel fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in men. Br J Nutr. 91, 591-599.
120. Tiwary C, Ward J, Jackson B. 1997. Effect of pectin on satiety in healthy US army adults. J Am Coll Nutr. 16, 423-428.
121. Haber GB, Heaton KW, Murphy D, Burroughs LF. 1977. Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet. 2, 679-682.
122. Di Lorenzo C, Williams C, Hajnal F, Valenzuela J. 1988. Pectin delays gastric emptying and increases satiety in obese subjects. Gastroenterology. 95(5), 1211-1215.
123. Wanders AJ, Jonathan MC, van den Borne JJ, Mars M, Schols HA, Feskens EJ et al. 2013. The effects of bulking, viscous and gel-forming dietary fibers on satiation. Br J Nutr. 109, 1330-1337.
124. Anderson JW. 2008. Dietary fiber and associated phytochemicals in prevention and reversal of diabetes. In: Pasupuleti VK, Anderson JW, eds. Nutraceuticals, Glycemic Health and Type 2 Diabetes. Ames, IA: Blackwell Publishing Professional, 111-142.
125. Alberti G, Zimmet P, Shaw J, Grundy S. 2006. The IDF Worldwide Definition of the Metabolic Syndrome. International Diabetes Federation. Available at: http://www.idf.org/metabolic-syndrome (accessed on March 11, 2015).
126. Pastors JG, Blaisdell PW, Balm TK, Asplin CM, Pohl SL. 1991. Psyllium fiber reduces rise in postprandial glucose and insulin concentrations in patients with non-insulindependent diabetes. Am J Clin Nutr. 53(6), 1431-145.
127. Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP, Sahagun AM. 2001. Effects of ispaghula husk and guar gum on postprandial glucose and insulin concentrations in healthy subjects. Eur J Clin Nutr. 55(4), 235-243.
128. McRorie J, Greenwood-Van Meerveld B, Rudolph C. 1998. Characterization of propagating contractions in the proximal colon of ambulatory mini pigs. Dig Dis Sci. 43(5), 957-963.
129. Greenwood-Van Meerveld B, Neeley D, Tyler K, Peters L, McRorie J. 1999. Comparison of effects on colonic motility and stool characteristics associated with feeding olestra and wheat bran to ambulatory mini-pigs. Dig Dis Sci. 44(7), 1282-1287.
130. Bassotti G, Crowell M, Whitehead W. 1993. Contractile activity of the human colon: Lessons from 24 hour studies. Gut. 34, 129-133.
131. Bassotti G, Germani U, Morelli A. 1996. Flatus-related colorectal and anal motor events. Dig Dis Sci. 41(2), 335-338.
132. Tomlin J, Read N. 1988a. Laxative properties of indigestible plastic particles. Br Med J. 297, 1175-1176.
133. Lewis SJ, Heaton KW. 1999. Roughage revisited: The effect on intestinal function of inert plastic particles of different sizes and shapes. Dig Dis Sci. 44, 744-748.
134. Francis CY, Whorwell PJ. 1994. Bran and irritable bowel syndrome: Time for reappraisal. Lancet. 344(8914), 39-40.
135. Grabitske HA, Slavin JL. 2009. Gastrointestinal effects of low-digestible carbohydrates. Crit Rev Food Sci Nutr. 49, 327-360.
136. Olesen M, Gudmand-Hoyer E. 2000. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr. 72, 1570-1575.
137. Suarez F, Springfield J, Furne J, Lohrmann T, Kerr P, Levitt M. 1999. Gas production in humans ingesting a soybean flour derived from beans naturally low in oligosaccharides. Am J Clin Nutr. 69, 135-139.
138. Lewis S, Burmeister S, Cohen S et al. 2005. Failure of dietary oligo-fructose to prevent antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 21, 469-477.
139. Cummings JH, Christie S, Cole TJ. 2001. A study of fructo-oligosaccharides in the prevention of travellers' diarrhoea. Aliment Pharmacol Ther. 15, 1139-1145.
140. Drakoularakou A, Tzortzis G, Rastall RA, Gibson GR. 2010. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea. Eur J Clin Nutr. 64(2), 146-152.
141. Tomlin J, Read N. 1988b. A comparative study of the effects on colon function caused by feeding ispaghula husk and polydextrose. Aliment Pharmacol Ther. 2(6), 513-519.
142. Marlett JA, Kajs TM, Fischer MH. 2000. An unfermented gel component of psyllium seed husk promotes laxation as a lubricant in humans. Am J Clin Nutr. 72, 784-789.
143. McRorie J, Daggy B, Morel J, Diersing P, Miner P, Robinson M. 1998. Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharmacol Ther. 12, 491-497.
144. Singh B. 2007. Psyllium as a therapeutic and drug delivery agent. Int J Pharm. 334, 1-14. Eherer A, Santa Ana C, Fordtran J. 1993. Effect of psyllium, calcium polycarbophil, and wheat bran on secretory diarrhea induced by phenolphthalein. Gastroenterology. 104, 1007-1012.
145. Qvitzau S, Matzen P, Madsen P. 1988. Treatment of chronic diarrhoea: Loperamide versus ispaghula husk and calcium. Scand J Gastroenterol. 23, 1237-1240.
146. Brandt LJ, Prather CM, Quigley EM, Schiller LR, Schoenfeld P Talley NJ. 2005. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol. 100, S5-S22.
147. Wenzl HH, Fine KD, Schiller LR et al. 1995. Determinants of decreased fecal consistency in patients with diarrhea. Gastroenterol. 108, 1729-1738.
148. Washington N, Harris M, Mussellwhite A, Spiller R. 1998. Moderation of lactulose-induced diarrhea by psyllium: Effects on motility and fermentation. Am J Clin Nutr. 67, 317-321.
149. Fujimori S, Tatsuguchi A, Gudis K et al. 2007. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease. J Gastroenterol Hepatol. 22, 1199-1204.
150. Spiller R, Aziz Q, Creed F et al. 2007. Guidelines on the irritable bowel syndrome: Mechanism and practical management. Gut. 56, 1770-1798.
151. Brandt LJ, Chey WD, Foxx-Orenstein AE et al. 2009. American College of Gastroenterology Task Force on IBS. An evidence-based systematic review on the management of irritable bowel syndrome. Am J Gastroenterol. 104(Suppl 1), S1-S35.
152. Bijkerk CJ, Muris JWM, Knottnerus JA, Hoes AW, De Wit NJ. 2004. Systematic review: The role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 19, 245-251.
153. Eswaran S, Muir J, Chey W. 2013. Fiber and functional gastrointestinal disorders. Am J Gastroenterol. 108, 718-727.
154. McRorie, J. 2013. Clinical data support that psyllium is not fermented in the gut. Letter to the Editor, Am J Gastroenterol. 108(9), 1541.
155. Ford AC, Talley NJ, Spiegel BM et al. 2008. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: Systematic review and metaanalysis. Br Med J. 337, a2313.
156. Thompson WG. 1994. Doubts about bran. Lancet. 344, 3.
157. Olesen M, Gudmand-Hoyer E. 2000. Efficacy, safety, and tolerability of fructo-oligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr. 72, 1570-1575.
158. Hunter JO, Tuffnell Q, Lee AJ. 1999. Controlled trial of oligo-fructose in the managementof irritable bowel syndrome. J Nutr. 129, 1451S-1453S.
159. Paineau D, Payen F, Panserieu S et al. 2008. The effects of regular consumption of shortchain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders. Br J Nutr. 99, 311-318.
160. Silk DBA, Davis A, Vulevic J et al. 2009. Clinical trial: The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 29, 508-518
161. Lembo T, Munakata J, Naliboff B, Fullerton S, Mayer E. 1997. Sigmoid afferent mechanisms in patients with irritable bowel syndrome. Dig Dis Sci. 42, 1112-1120.
162. Serra J, Azpiroz F, Malagelda J. 1995. Perception and reflex responses to intestinal distention in humans are modified by simultaneous or previous stimulation. Gastroenterology. 109, 1742-1749.
163. Zighboim J, Talley N, Phillips S, Harmsen W, Zinmeister A. 1995. Visceral perception in irritable bowel syndrome. Dig Dis Sci. 40, 819-827.
164. McRorie J, Zorich N, Riccardi K, Bishop L, Filloon T, Wason S, Giannella R. 2000. Effects of olestra and sorbitol consumption on objective measures of diarrhea: Impact of stool viscosity on common gastrointestinal symptoms. Regul Toxicol Pharmacol. 31(1), 59-67.
165. Crowell M, Bassotti G, Cheskin L, Schuster M, Whitehead W. 1991. Method for prolonged ambulatory monitoring of high-amplitude propagated contractions from colon. Am J Physiol. 261, G263-G268.